Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

2008/05/01 by Julian R. Molina, Ping Yang, Stephen D. Cassivi +2 · 3,088 citations
Medicine · #Adenocarcinoma #Cancer #Chemotherapy #Disease #Internal medicine #Lung Cancer Diagnosis and Treatment #Lung Cancer Research Studies #Lung Cancer Treatments and Mutations #Lung cancer #Medicine #Oncology #Radiation therapy #Surgery #Treatment of lung cancer

paper · doi:10.4065/83.5.584

published in Mayo Clinic Proceedings 83(5), 584-594 (Elsevier BV)

openalex publication_date 2008/05/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma
• Small Cell Lung Cancer

Cited by

• Ti0.8O2 Nanosheets Inhibit Lung Cancer Stem Cells by Inducing Production of Superoxide Anion
• Network Meta Analysis of Mean Survival
• Estimation of Causal Effects of Multiple Treatments in Observational Studies with a Binary Outcome
• New Insight into the Role of AhR in Lung Carcinogenesis
• Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung Cancer
• Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progression
• A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations
• Ampelopsis japonica enhances the effect of radiotherapy in non-small cell lung cancer
• Infratemporal Fossa Metastasis of Non-Small-Cell Lung Adenocarcinoma: A Case Report and Literature Review
• DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. [europepmc]
• Network meta-analysis of survival data with fractional polynomials. [europepmc]
• Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324. [europepmc]
• EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. [europepmc]
• Lung cancer screening. [europepmc]
• Integrating multiple social statuses in health disparities research: the case of lung cancer. [europepmc]
• Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. [europepmc]
• Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. [europepmc]
• MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. [europepmc]
• Preclinical Murine Models for Lung Cancer: Clinical Trial Applications. [europepmc]
• Delivery strategies and potential targets for siRNA in major cancer types. [europepmc]
• Cancer and liver cirrhosis: implications on prognosis and management. [europepmc]
• Link Between m6A Modification and Cancers. [europepmc]
• Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. [europepmc]
• Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences. [europepmc]
• PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway. [europepmc]
• Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. [europepmc]
• Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. [europepmc]
• Development and validation of an immune-related prognostic signature in lung adenocarcinoma. [europepmc]
• Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. [europepmc]
• Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy. [europepmc]
• Emerging roles of SIRT6 in human diseases and its modulators. [europepmc]
• The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology. [europepmc]
• Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. [europepmc]
• Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). [europepmc]